objective In 4-to 8-year-old Zambian children (n = 744), we evaluated the effects of adjusting for inflammation (a1-acid glycoprotein >1 g/l), with or without additional adjustment for malaria, on prevalence estimates of iron deficiency (ID) and iron deficiency anaemia (IDA) during low malaria (LowM) and high malaria (HighM) transmission seasons.
Introduction
Globally, an estimated 40% of preschool-aged children are anaemic [1] . Anaemia in early childhood is associated with delayed cognitive and physical development [2] . The burden of anaemia is especially high in sub-Saharan Africa, where malaria and iron deficiency (ID) -two important risk factors -often coexist [3, 4] . Although iron interventions in childhood are critical, this is complicated in malaria-endemic regions where universal iron supplementation is associated with adverse outcomes in children [5] . Hence, in malaria-endemic settings, it is particularly important that the delivery of iron interventions be guided by prior assessment of individual and population needs.
Two biomarkers are recommended by the WHO and CDC for defining population iron status [6] : serum ferritin, which is the iron storage protein usually found in the parenchymal and reticulo-endothelial cells of the liver, spleen and bone marrow, and in low concentrations in the plasma proportional to the body stores [7, 8] ; and soluble transferrin receptor (sTfR), the truncated version of the transmembrane transferrin receptor protein, which increases in concentration with tissue demand for iron. Both biomarkers are affected by inflammation [6] , and hence, their utility remains controversial in regions with a high prevalence of infections [9] [10] [11] .
To overcome the inflammation-induced biases in serum ferritin and sTfR in the context of public health research and practice, WHO and CDC advise scientists and programme managers to adjust measured concentrations using acute-phase protein concentrations, in particular Creactive protein (CRP) and/or a 1 -acid glycoprotein (AGP) [3, 4] . The adjustment factor is the relative difference in biomarker concentrations between individuals with and without inflammation. This assumes that the magnitude of the difference, and hence the correction factor, is independent of the type of stimulus or infection inducing the inflammation [12] [13] [14] . This assumption has been challenged by the several recent studies that reported a greater elevation in serum ferritin and sTfR in children with malaria-related inflammation [15] [16] [17] . Researchers now question whether it is necessary to adjust for both malaria and inflammation, as opposed to inflammation alone [15, 18] . More importantly, evidence is lacking on whether malaria independently influences estimates of ID and ID with anaemia (IDA), beyond variation explained by conventional acute-phase proteins. This study was designed to determine whether serum ferritin and sTfR concentrations, as well as prevalence estimates of ID and IDA, differed by malaria status, even after correcting for inflammation. The study was also designed to quantify residual differences, if any, in the population prevalence of ID or IDA adjusting for inflammation alone or adjusting for both inflammation and malaria.
Methods

Ethics
Ethical approval was obtained from the Institutional Review Board of the Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA, and the Ethics Review Committee of the TDRC, Ndola, Zambia. Authority to conduct research was obtained from the Ministry of Health.
Subjects and data collection
This study was conducted in Mkushi District, Zambia, a malaria-endemic area with a high burden of anaemia [19] [20] [21] . It was nested in a cluster-randomised controlled trial to evaluate the impact of provitamin A carotenoidbiofortified maize meal consumption on vitamin A status in preschool-aged children (registered as NCT01696148 at www.clinicaltrials.gov) [22] . We conducted baseline (~September 2012) and endline (~March 2013) surveys in the low and high malaria transmission seasons, respectively. We collected data on socio-economic status, diet and morbidity, and measured height with a Shorr Board to the nearest 0.1 cm and weight with a SECA 874 digital scale to the nearest 0.1 kg. Axillary temperature was taken with a digital thermometer, and children with high fever (axillary temperature >39°C) were referred to the nearest health centre.
Trained laboratory technicians collected 7 ml of blood by antecubital venipuncture (Covidien Monoject sterile tubes with no additives). Field diagnosis of malaria was performed by rapid diagnostic test (RDT; SD Bioline Malaria Ag P.f, Standard Diagnostics, Yongin, South Korea; 05FK50). Children testing positive were treated with Coartem according to Zambian national guidelines [23] . Haemoglobin was assessed using a HemoCue Hb 201+ hemoglobinometer (Angelholm, Sweden). Thick and thin venous blood films were prepared using~2 ll and 10 ll of blood, respectively. Whole blood was put into cooler boxes containing ice packs and transported to the field laboratory. Samples were centrifuged for 10 min under dim light. Serum was aliquoted into pre-labelled cryovials and transported in liquid nitrogen to the Tropical Diseases Research Centre (TDRC) for storage at À80°C until analysed.
Laboratory analyses
All laboratory assays were performed at TDRC in Ndola, Zambia. Malaria slides were stained with 3% Giemsa, washed, dried and read independently twice by two technicians using light microscopy. A third independent reading was carried out for discordant results. For each positive reading, the corresponding thin film was read to determine the Plasmodium species. We used commercial enzyme-linked immunosorbent assays to determine serum concentrations of AGP (Abcam, Cambridge, USA; catalog # ab108854), serum ferritin (Ramco Lab. Inc, Texas, USA; catalog # S-22) and sTfR (Ramco Lab. Inc, Texas, USA; catalog # TFC-94).
Sample size consideration
To detect a difference in serum ferritin concentrations of 2.0 lg/l between children with and without inflammation (AGP >1 g/l), we required a sample size of 55 at 90% power and 5% type 1 error, assuming a within-group standard deviation in serum ferritin of 2.2 lg/l [16] and a 40% prevalence of inflammation.
Definition of malaria and inflammation
As both RDT-and microscopy-defined malaria were associated with significant elevations in serum ferritin and sTfR, we considered children malaria positive if they had P. falciparum parasitaemia of any density, a positive RDT, or both, and malaria negative if both RDT and microscopy were negative. Inflammation was defined as AGP >1.0 g/l. We excluded all children with fever from analyses to focus on subclinical malaria -which is both more prevalent more likely to be missed in surveys -as opposed to symptomatic malaria.
Definition of iron status and anaemia
We defined iron deficiency as serum ferritin <12 lg/l in children <5 years and serum ferritin <15 lg/l in older children [6] , or as sTfR >8.3 mg/l [24] . Serum ferritin and sTfR were examined against cut-offs in unadjusted and adjusted (for inflammation and/or inflammation and malaria, as described) states. Anaemia was defined as haemoglobin <110 g/l or <115 g/l for children <5 year or ≥ 5 year, respectively [6] . Iron deficiency anaemia was defined as anaemia with concurrent ID, based on either low serum ferritin or sTfR.
Statistical analyses
Serum ferritin and sTfR were natural log-transformed. We constructed two adjustment models. For adjustment 1, we dichotomised children into a reference (AGP ≤1 g/l) or an inflammation (AGP >1 g/l) group. For both serum ferritin and sTfR, we divided the geometric mean concentration of the inflammation group by the geometric mean concentration of the reference group. The adjustment factor was defined as the inverse of this ratio [4] . Adjusted concentrations were computed by multiplying each individual's measured serum ferritin or sTfR concentration by the adjustment factor. Adjustment 2 was made using similar procedures, except that incorporated classifications of both inflammation and malaria, grouping children into a reference category (AGP ≤1 g/l and malaria negative), to which we compared children with inflammation only (AGP >1 g/l and malaria negative), malaria only (AGP ≤1 g/l and malaria positive) or malaria with inflammation (AGP >1 g/l and malaria positive). In this four-group procedure, adjusted concentrations were computed by multiplying the group-specific adjustment factors by each individual's measured serum ferritin or sTfR concentration. Adjusted concentrations were generated separately for low and high malaria transmission seasons, as the intensity of inflammation was hypothesised to be greater in the high transmission season. In both adjustments 1 and 2, statistical significance of the geometric mean ratios (comparing each group to the reference) was tested using a linear regression function with a robust variance estimator. To determine the malaria-specific changes in ID and IDA prevalence, we stratified children by malaria status and estimated prevalence separately for each group. Next, we applied adjustments 1 and 2 to the two malaria groups to determine the comparability of ID or IDA after adjusting for either inflammation alone or adjusting for both inflammation and malaria. Statistical significance of the differences in ID or IDA across malaria status was tested using the Chi-squared test. Finally, we estimated the magnitude of change in population prevalence of ID or IDA comparing adjustment 1 to adjustment 2 and tested the difference by McNemar's test. Analyses were performed separately for both low and high malaria transmission seasons. Statistical significance was set at P < 0.05. All analyses were conducted with STATA 13 software (StataCorp, College Station, Texas).
Results
Study sample
Of the 1024 children enrolled in the trial, we excluded children (n = 141) due to missing data for one or more variables of interest (serum ferritin, sTfR, AGP or malaria) at either time point. To estimate the effects of subclinical malaria, we excluded an additional 139 children who had high axillary temperature (≥37.5°C at one or both surveys), leaving a final analytic sample of 744 children ( Figure 1 ). Baseline socio-demographic characteristics of this subsample (Table 1) were similar to those of excluded children, except that excluded children werẽ 3 months younger (P = 0.03) and had a higher prevalence of diarrhoea in the past 2 weeks (P = 0.04). Overall, the study population reflected a rural community with high literacy (>82% of household heads could read or write in English or Bemba) and reliance on agricultural activities (more than a fourth of households). Our subsample had a roughly equal representation of boys and girls, with a mean age of 69 months and 34% below 5 years of age. Prevalence of stunting and underweight was 29% and 8%, respectively.
Distributions of malaria, inflammation and iron deficiency
Malaria prevalence differed by definition and season, with prevalence estimates higher for the more sensitive RDT than the more specific microscopy ( Table 2 ). All malaria cases were determined to be Plasmodium falciparum. As would be expected, both malaria prevalence and the elevated AGP prevalence were higher in the high malaria transmission season. The prevalence of anaemia also increased from the low to high malaria season, although mean haemoglobin did not differ by season. The distributions of both serum ferritin and sTfR shifted to higher values from the low to high malaria transmission season, regardless of inflammation status. Consequently, prevalence estimates of ID declined when based on serum ferritin (from 8% to 5%), while doubling when based on sTfR (from 27% to 54%. The proportions of children in each of the inflammatory groups were 42.7% (reference), 32.0% (inflammation alone), 12.2% (malaria but no inflammation) and 13.0% (malaria with inflammation) in the low malaria transmission season, and corresponding estimates of 19.9%, 31.3%, 7.0% and 41.8% in the high malaria transmission season.
Iron biomarkers by inflammation and malaria category
In both seasons, concentrations of serum ferritin and sTfR peaked when inflammation and malaria coexisted (Figures 2 and 3 ), resulting in a 40.7% or 276% increase in serum ferritin concentrations in the low and high malaria transmission seasons, respectively, and a relatively modest increase in sTfR of 31% or 19% in the low and high malaria transmission seasons, respectively (Table 3) .
Application of adjustment factors
Correcting for both malaria and inflammation as opposed to inflammation alone modestly increased the serum ferritin-based prevalence of ID and IDA, while decreasing the sTfR-based prevalence (Table 4) . For serum ferritin, the concurrent adjustment for malaria further increased the ID prevalence by about 2% in the high transmission season. In the low transmission season, however, the serum ferritin-based ID, corrected for inflammation alone (8.7%) or corrected for both inflammation and malaria (9.1%), was statistically similar (P > 0.05). For sTfR, the ID prevalence estimate decreased from 27% (unadjusted) to 24% when corrected for inflammation only, further decreasing to 19% (P < 0.001) after correcting for both inflammation and malaria in the low malaria season. The additional malaria effect observed in the high malaria season was a more modest reduction from 46.4% (when corrected for inflammation only) to 45.3% when corrected for both inflammation and malaria (P < 0.05). Changes in IDA, after correction for either inflammation alone or with malaria, were consistent, both in magnitude and direction, with the observed changes in the respective iron status biomarkers (Table 4 ).
Discussion
Our study demonstrates that serum ferritin and sTfR concentrations are significantly elevated during inflammation, as is commonly understood, but more so in the presence of malaria parasitaemia. Consequently, correcting for both malaria and inflammation, as opposed to inflammation alone, tended to minimise differences in ID or IDA prevalence estimates across malaria status, particularly when based on serum ferritin. At the population level, these malaria-specific effects translated into modest, yet statistically significant changes in the estimated prevalence of ID or IDA. The accurate interpretation of iron status markers has important implications for defining prevalence of anaemia or iron deficiency in public health research and population status surveys, as well as estimating the potential impact of control efforts. This is particularly important in malaria-endemic regions, where evidence suggests that the confounding effect of inflammation on serum ferritin [4] and soluble transferrin receptor [12] may be exacerbated by concurrent Plasmodium falciparum infections [15, 17] . Our data suggest that adjustment for both inflammation and malaria parasitaemia can improve the reliability of ID and IDA prevalence estimates within and across malaria seasons.
The observed malaria-associated changes in serum ferritin, sTfR and ID prevalence are similar to patterns reported by two recent studies [15, 18] . In 6-to 23-month-old Burkinabe children, Wessells et al. estimated a serum ferritin-based ID prevalence of 40% among malaria-negative children and 5% among malaria-positive children after adjusting for inflammation [15] . However, this study did not find an independent effect of inflammation on sTfR, and hence did not report the sTfR-based estimates. Our findings regarding sTfR are consistent with observations reported in a study by Righetti et al., who reported independent effects of malaria and inflammation on sTfR concentrations in a cohort of Ivorian infants (n = 90) and school-aged children (n = 150) [18] . Our †Malaria defined as either-positive RDT or microscopy or both. ‡WHO age-specific cut-offs: <110 g/l or <115 g/l for children <5 year or ≥ 5 year, respectively, for haemoglobin; < 12 lg/l or <15 lg/l for children <5 year or ≥5 year, respectively, for ferritin.
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volume 23 no 1 pp 53-62 january 2018 study differs with respect to the definition of inflammation, in that we relied solely on AGP concentrations; however, Righetti et al. did test the relative impact of using both CRP and AGP vs. AGP alone and reported no difference between the two approaches. Thus, our reliance solely on AGP is unlikely to have underestimated the impact of inflammation, likely because the inclusion of malaria parasitaemia may have captured most cases of elevated CRP. We also opted for a more sensitive definition of malaria -positive HRP-2 or positive microscopy or both -because we found that both definitions were associated with significant elevations in both serum ferritin and sTfR. Our findings of an independent malaria effect compound the challenge of interpreting serum ferritin and sTfR values, particularly at the individual level. Unfortunately, the lack of a gold standard iron status marker makes it challenging to draw conclusions on whether the additional adjustment for malaria improves the reliability of serum ferritin and sTfR. Adding to this dilemma is the substantial disparity in ID or IDA prevalence estimates between serum ferritin and sTfR, which has been reported previously [15] [16] [17] . The observed differences in the serum ferritin-or sTfR-based estimates of IDA prevalence lead to conflicting conclusions regarding the specific, underlying causes of anaemia. The low prevalence of IDA when based on serum ferritin would suggest that much of the problem of anaemia in this population is driven by causes other than low iron stores and that iron interventions will likely not have a significant impact on anaemia. The reverse conclusion is implied when the IDA prevalence estimate is based on sTfR. These limitations underscore the need for continued research to improve interpretation of iron status markers. A multiple-indicator diagnostic criteria requiring at least two abnormal values of serum ferritin, sTfR and zinc protoporphyrin have been proposed by Grant et al. [25] . If this approach were adopted, >50% of serum ferritinbased ID cases -likely true cases of ID -would have been categorised as iron-adequate due to a lack of overlap between cases with low serum ferritin and elevated sTfR. Hence, these criteria may not necessarily improve diagnosis, but may instead increase the false-positive rate relative to sTfR and, perhaps more importantly, increase the false-negative rate when compared to serum ferritin. Although the accuracy of either iron status indicator (i.e. serum ferritin or sTfR) for diagnosis of ID or IDA remains uncertain, it is plausible, considering the distribution of haemoglobin, that prevalence based on sTfR is overestimated. Within the limitations of the adjustment procedures applied here, we posit that the serum ferritinbased prevalence estimates of ID or IDA are preferred in this context.
Although the mechanisms underlying the exacerbated response in serum ferritin and sTfR to malaria are not completely understood, the hepcidin pathway may provide a plausible explanation [26] . During malaria episodes, the increased lysis of erythrocytes, and the †Values are geometric means and 95% confidence intervals; Adjustment 1: reference = AGP ≤1 g/l; inflammation = AGP >1 g/l with or without malaria. Adjustment 2: reference (no inflammation; malaria negative); inflammation only (AGP >1 g/l and malaria negative); malaria only (AGP ≤1 g/l; malaria positive); malaria with inflammation (AGP >1 g/l; malaria positive); % difference defined as the geometric mean in each group divided by that of the reference and multiplied by 100; adjustment factor defined as inverse of the ratio of geometric mean ferritin in each group to that of reference group. Statistical significance of adjustment factor tested with linear regression model, using the log-normalized concentrations and robust variance estimator.
resulting release of malaria parasites into the blood stream, stimulates the production of pro-inflammatory cytokines by macrophages, and as results, triggering the hepatic synthesis of hepcidin [27] . As part of the immune response to withhold iron from invading parasites, hepcidin triggers a state of intracellular iron sequestration by internalising ferroportin, upregulating the synthesis of serum ferritin [28] [29] [30] [31] [32] . The resulting transient extracellular iron deficiency stimulates an increase in the membrane-bound transferrin receptor, and hence sTfR, possibly to counteract the interruption in delivery of iron to the tissues [33, 34] . Our findings suggest a strong potential for misclassification at the individual level, which may influence prevalence estimates in the context of population-based research or practice. The additional effect of controlling for inflammation and malaria on population prevalence of ID was less noticeable, likely explained by the fact that most cases of malaria also had elevated AGP. Decisions on whether to adjust for malaria in addition to inflammation should carefully consider the transmission intensity, the availability of resources for malaria assessment and the overall objective of the iron status assessment. Our findings suggest that where resources are available, the assessment of both malaria and inflammation should be made and should be used in estimating context-specific factors. This is particularly true for establishing the iron status of individuals in high transmission seasons. Given the varied application of adjustment methods, it is also important that both adjusted and unadjusted concentrations of these biomarkers be reported to enable a more comprehensive interpretation of the iron status of individuals and populations. *P-values represent test of difference comparing the change in prevalence after adjusting for inflammation alone vs. corresponding change after adjusting for both inflammation and malaria. †Values are n (%) children with iron deficiency (ID) or iron deficiency anaemia (IDA) corrected for inflammation only or in combination with malaria. ID defined as serum ferritin <12 lg/l or <15 lg/l for children <5 year or ≥5 year, respectively, or elevated sTfR (>8.3 mg/l) and IDA defined as ID with concurrent anaemia (haemoglobin <110 g/l or <115 g/l for children <5 year or ≥ 5 year, respectively).
